Fjällbrant H, Ridell M, Larsson L O
Dept of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Göteborg, Sweden.
Eur Respir J. 2001 Aug;18(2):376-80. doi: 10.1183/09031936.01.00086901.
The aim was to study the tuberculin skin test in relation to immunological in vitro reactions in bacille Calmette-Guerin (BCG)-vaccinated healthcare workers. The present study was performed in Sweden, a country with a low incidence of tuberculosis, a high BCG vaccination efficacy and high tuberculin conversion rates. BCG-vaccinated healthcare workers (n=381) were tuberculin skin tested. From these, 11 subjects with negative tuberculin reactions (<6 mm) were matched for age and sex with 11 subjects with large positive reactions (> or = 15 mm). Lymphocyte transformation and the production of interferon-gamma (IFN-gamma) were analysed after stimulation in vitro of peripheral blood mononuclear cells with tuberculin purified protein derivative, heat-killed tubercle bacilli and a culture filtrate from tubercle bacilli. In the tuberculin-positive group the lymphocyte transformation response was 2-3 times larger, and IFN-gamma production was 7-10 times larger, than in the tuberculin-negative group (p<0.001). The present results suggest that a positive tuberculin skin test in bacille Calmette-Guerin-vaccinated subjects indicates a stronger immune response of the protective T-helper 1-type than does a negative test. In similar settings, the study supports the traditional practice of regarding the tuberculin skin test in bacille Calmette-Guerin-vaccinated subjects as an indicator of a protective immune response against tuberculosis.
目的是研究卡介苗(BCG)接种的医护人员中结核菌素皮肤试验与体外免疫反应的关系。本研究在瑞典进行,该国结核病发病率低、卡介苗接种效果高且结核菌素转化率高。对381名接种卡介苗的医护人员进行了结核菌素皮肤试验。从这些人员中,选取11名结核菌素反应阴性(<6mm)的受试者,按照年龄和性别与11名结核菌素反应强阳性(≥15mm)的受试者进行匹配。用结核菌素纯化蛋白衍生物、热灭活结核杆菌和结核杆菌培养滤液对外周血单个核细胞进行体外刺激后,分析淋巴细胞转化和γ干扰素(IFN-γ)的产生情况。结核菌素阳性组的淋巴细胞转化反应比结核菌素阴性组大2至3倍,IFN-γ产生量比结核菌素阴性组大7至10倍(p<0.001)。目前的结果表明,在接种卡介苗的受试者中,结核菌素皮肤试验阳性表明其保护性辅助性T1型免疫反应比阴性试验更强。在类似情况下,该研究支持将接种卡介苗受试者的结核菌素皮肤试验视为针对结核病的保护性免疫反应指标的传统做法。